Complex Presentations, Identification and Treatment of Mast Cell Activation Syndrome and Associated Conditions: A Case Report.

Mast Cell Activation Syndrome (MCAS) is only a recently recognized, multisystem disorder that has been historically underrecognized due its estimated high prevalence. Recognition, testing, and treatment all pose unique challenges to condition management. The condition warrants more concern due to its prevalence and under recognition.

Treatment of Epstein-Barr Induced Hepatitis with High Dose Intravenous Vitamin C: A Case Report.

Introduction: Vitamin C has been previously studied for use with acute and chronic Epstein-Barr Virus (EBV) and hepatitis C. However, it has never been evaluated for its impact on EBV induced hepatitis. In this case report, we present a patient's history with EBV induced hepatitis treated with high dose vitamin C.

Xanthohumol microbiome and signature in adults with Crohn's disease (the XMaS trial): a protocol for a phase II triple-masked, placebo-controlled clinical trial.

Background: Xanthohumol (XN), a bioactive flavonoid from Humulus lupulus with anti-inflammatory properties, has potential benefits for patients with Crohn's disease (CD), a type of inflammatory bowel disease. We recently completed and published results of a placebo-controlled phase I clinical trial demonstrating the safety and tolerability of 24 mg XN daily for 8 weeks. The present study aims to evaluate the safety and tolerability of the same dose of XN adults with clinically active CD in a placebo-controlled phase II clinical trial.

Naturopathic Approach to Functional Dyspepsia: A Case Report.

Functional dyspepsia is a common presenting concern that includes symptoms such as gastrointestinal reflux, postprandial bloating, and abdominal pain. Aside from mainstay conventional therapies such as proton pump inhibitors and antacid tablets that seek to manage symptoms, naturopathic therapies can similarly offer symptom relief and simultaneously address factors underlying functional digestive disturbances. In this case, a 25-year-old female and first year graduate student presented with abdominal bloating, epigastric pain, flatulence, eructations, reflux, and straining with stool.

Fish Oil and BCQ™ as a Novel Treatment Approach to Primary Erythromelalgia: A Case Study.

Erythromelalgia (EM) is a rare disorder, of which the pathophysiology is poorly understood. Though primary EM is thought to be an autosomal-dominant inherited disorder or of idiopathic origin, secondary EM is associated, most often, with myeloproliferative diseases. Pain management is the primary therapeutic target, however, individual patient responses vary widely, and no single treatment has been determined to be effective.

Low Dose Naltrexone in Conjunction With the Wahls Protocol to Reduce the Frequency of Chronic Migraines in a Patient With Multiple Sclerosis: A Case Study.

This case study investigates the efficacy of low dose naltrexone (LDN) and the Wahls Protocol in reducing the frequency and severity of chronic migraine headaches in a 62-year-old White female with multiple sclerosis. Migraines are common among the many debilitating symptoms of multiple sclerosis. A therapeutic intervention of low dose naltrexone titrated to 4.

Naturopathic Treatment of an Inflamed Epidermoid Cyst: A Case Report.

This case report examines the treatment of a 55-year-old White female who initially presented to the National University of Natural Medicine (NUNM) Lair Hill Health Center with a chief complaint of an inflamed epidermoid cyst of the posterolateral aspect of the left upper arm. The patient attended several visits over the course of 2 months. Initial treatment recommendations included oral antibiotics, which the patient declined, and natural treatments used to decrease progression of infection and to increase skin healing.

Labeling of Cannabidiol Products: A Public Health Perspective.

Interest in the therapeutic use of cannabidiol (CBD) has reached a fever-pitch in recent months, as CBD-containing products appear everywhere from online retailers to grocery stores and gas stations. The widespread availability of hemp-derived CBD products is confounding given that CBD is a U.S.

L-Methylfolate as a Monotherapy for Treatment-Resistant Depression: A Case Study.

This case study examines a 49-year-old Asian American female patient with long-standing fatigue and depression (20 years or more), for which pharmaceutical antidepressant therapies have been ineffective. History, physical examination, laboratory tests, and Genomind Genecept Assay genetic testing were used to determine symptom severity, investigate the presence of organic causes of fatigue, and provide a potential novel monotherapy for depression. Therapeutic intervention included a slow titration of L-methylfolate to an eventual therapeutic daily dose of 15 mg.

Regulatory Status of Cannabidiol in the United States: A Perspective.

Cannabidiol (CBD) is 1 of > 100 cannabinoids found in L. ( or ). Despite its complex and rapidly evolving regulatory status in the United States, projected retail sales of CBD products-hemp, Cannabis and pharmaceutical-are as high as $1.

A Cross-Sectional Study of Cannabidiol Users.

Preclinical and clinical studies suggest that cannabidiol (CBD) found in Cannabis spp. has broad therapeutic value. CBD products can currently be purchased online, over the counter and at Cannabis-specific dispensaries throughout most of the country, despite the fact that CBD is generally deemed a Schedule I controlled substance by the U.